first_img Related HOKA ONE ONE has announced the signing of German triathlon legend Jan Frodeno. In a multi-year deal, the Olympic champion and three-time winner of the IRONMAN World Championship in Kona will don the brand’s high-performance footwear.Affectionately known as ‘Frodo’, the globally-renowned German – who sealed his third IRONMAN World Championship title last year – will put his HOKA shoes into action for the next three seasons.Frodeno will predominantly opt for HOKA’s lightweight racing shoes when it comes to competing on the world stage, whilst also maximising use of the best-selling Clifton and other cushioned models for training sessions.“I want to be at the very top of the game for another three years and, with the support of HOKA, I believe I have the shoes on my feet to do just that,” said Frodeno. “I am heavily invested in high performance – a passion and dedication that is clearly also shared by the HOKA brand.”As the Official Running Shoe sponsors of IRONMAN North America and IRONMAN Europe, the presence of HOKA on the triathlon scene has increased notably in recent years. The company noted that… ‘Claiming the No.1 spot for shoe counts on several occasions at the [IRONMAN] World Championship in Kona, the brand’s latest signing further boosts its pedigree within the sport.’“We are extremely excited at the prospect of working with one of triathlon’s greatest ever stars,” said Mike McManus, HOKA’s Global Director of Sports Marketing. “Both Jan and HOKA are deeply rooted in high-performance, and both have a proven pedigree in delivering results when it matters, so we see our partnership as the perfect fit.“We’re truly thankful to Jan for the trust he has placed in HOKA to help take his performance forward in the coming years.”Frodeno joins a host of other high-performance triathletes on the HOKA roster for 2020, including three-time IRONMAN World Champion Mirinda Carfrae, runner-up in Kona last year Tim O’Donnell, third-place finisher at Kona for 2017 & 2019 Sarah Crowley, fellow World Championship podium athlete Heather Jackson, as well as Swede Patrik Nilsson and Briton Joe Skipper.www.hokaoneone.comwww.hokaoneone.eulast_img read more

first_img“We don’t want to be part of that where somebody’s going to sneak up on us,” Reiter said. “I think definitely we’re going to be ready to go this weekend.”But 149-pounder Dustin Schlatter might not.Robinson said Schlatter has had the flu the past few days and might take the night off to rest, especially given that Minnesota will likely have little trouble without him.Whether Schlatter goes or not, Robinson still doesn’t share his wrestlers’ intensity about getting up for the Ohio State meet.“You can’t keep a team up all the time, and when you do, you burn them out,” Robinson said. “So you kind of go into it with a more laid-back attitude, realizing that the big dual meet will be Sunday against Penn State.”Because of the focus on the Nittany Lions, Travis Lang will wrestle at 125 and Mitch Kuhlman will wrestle at 197 on Sunday ” just as it was last weekend when Minnesota saved them for the tougher Iowa dual.The meet against Penn State features a big matchup at 184 pounds between 13th-ranked Kish and top-ranked Eric Bradley, who beat Kish 3-2 last year at the Big Ten Championships.But even with matchups like that on Sunday, Reiter said the Gophers don’t want to just coast through Columbus.“We want to go out there and just dominate every match because that will show everybody in the Big Ten that we’re not just a one- or two-week team,” Reiter said. “We want every team to go home at night and look on the Internet and see the score that we put up against them and be scared to wrestle us.” Friday against Ohio State overshadowed by Penn State David McCoyJanuary 27, 2006Jump to CommentsShare on FacebookShare on TwitterShare via EmailPrintSometimes, a 13 point margin of victory just isn’t good enough.That’s Minnesota wrestler Roger Kish’s point of view.And why should it be, when Kish and his Gophers teammates know they could wrestle even better?Coach J Robinson gave his team a “C’ for their performance seven days ago in the Gophers’ 24-11 win in their Big Ten opener against then-No. 16 Northwestern.Even though Minnesota won, Robinson said he felt the team was looking ahead to Sunday’s matchup with then-No. 7 Iowa.So when No. 1 Minnesota (14-0, 2-0 Big Ten) takes on unranked Ohio State (5-6, 0-1 Big Ten) tonight at 6 in Columbus, Ohio, Kish said the Gophers won’t be having any of that this time around.“I’d say last week we had our heads set on Iowa and maybe looked past Northwestern a little bit, which we found out was a mistake,” Kish said. “And a few of us wrestled kind of flat and we lost a couple weight classes we could have won. But I think we kind of learned our lesson.”Sunday’s meet at No. 9 Penn State (8-2, 2-0 Big Ten) is clearly the one requiring more preparation, and even though a win tonight over the struggling Buckeyes seems a near-guarantee, 133-pounder Mack Reiter said that isn’t the point.Reiter recalled the fact that Minnesota was picked to lose to both Oklahoma State and Iowa so far this season but came out on top both times.last_img read more

first_imgGophers swept by Penn StateMinnesota couldn’t contain the Nittany Lion offense as they were outscored 14-5.Sydni RoseForward Blake McLaughlin chases after the puck during the game against the Penn State at 3M Arena at Mariucci on Friday, Nov. 15. Julianna LandisNovember 19, 2019Jump to CommentsShare on FacebookShare on TwitterShare via EmailPrintThe Gophers were overpowered at home this weekend, falling in a pair home games to the then-No. 8 ranked Penn State Nittany Lions. Minnesota couldn’t stop Penn State throughout the weekend, getting outscored 14-5. The sweep drops the Gophers to 4-6-2 on the season. Penn State pours it on late, grabs 8-2 victory in the series openerHaving been denied an early goal in the first period, Penn State wasted no time getting on the board once the second got underway. They scored four goals in the middle frame, two of them coming just over a minute apart. Sam Sternschein got the scoring started for the Nittany Lions, and Kevin Wall followed up with his first goal of the season to put the Gophers to a quick two-goal deficit. Penn State took a shot at every opportunity they could while preventing the Gophers from getting any momentum going the other way. The Gophers have struggled with preventing turnovers this season, and it plagued them once again from the start of the game, where turnovers created many of the opportunities for the Nittany Lions.Penn State dominated the score sheet, putting the puck in the back of the net two more times before the Gophers were able to respond to make the game 4-1 following a goal from Jaxon Nelson 12:18 into the second period. Minnesota had a brief energy surge following that goal and was able to win a few face-offs and put up some shot attempts, but they were unable to add to their lone goal for the rest of the period.Just as in the second period, the Penn State scored just moments after puck drop in the third period as Liam Folkes scored in 27 seconds to make it a 5-1 game. After that goal, it was clear that it was likely too late for a successful comeback. Minnesota took goaltender Jack LaFontaine out of the game and replaced him with freshman Justen Close. It seemed to make little difference to Penn State who was in net for Minnesota because they scored three more goals by the end of the night. Sampo Ranta, who had been one of the most active forwards for the Gophers, scored his third goal of the season halfway through the third period to put the score at 8-2, but head coach Bob Motzko said it was simply “too little too late.”  Gopher start hot, fade lateMinnesota got off to a promising start after Friday’s game, going up 2-0 on the Nittany Lions. After that, however, Penn State scored five unanswered goals to sweep the series with another high-scoring win, this time 6-3.Penn State cut the lead in half behind a goal from Sternchein on the power play. Ranta added his second goal of the series to bring the lead back to two, but that was the last response the Gophers would be able to create.Goals from Folkes and Nate Sucese had the game tied by the 12th minute of the second period, and the Nittany Lions returned to the final frame to score three more unanswered goals on Minnesota’s Jared Moe, who posted a .806 save percentage on the night and made 25 saves.  Penn State’s high-octane offense lit the lamp all through the final frame, scoring in the beginning, middle and end minutes of the game. In the end, Minnesota couldn’t get out of their own way, resulting in the team’s second sweep of the season. “The mistakes we made were glaring, and that’s too good of a hockey team to make those mistakes [against],” Motzko told the media. “Tip your hat to Penn State, they have an enormous amount of talent …those guys capitalized when they had the opportunity.” Minnesota will continue their home stand against border rival No. 16 Wisconsin on Friday, Nov. 22 at 7:00 p.m.last_img read more

first_imgApr 6, 2012 (CIDRAP News) – The intravenous antiviral peramivir was used in close to 1,300 severely ill patients under an emergency authorization during the 2009 flu pandemic, but its impact and safety profile remain unclear, in part because of patchy data collection, according to reports and commentary published in Clinical Infectious Diseases (CID) this week.The Centers for Disease Control and Prevention (CDC) estimated that 1,274 patients received the IV drug under an Emergency Use Authorization (EUA). Food and Drug Administration (FDA) officials estimated that about 16% of the patients died, which is in the range of fatality rates reported for hospitalized H1N1 patients generally, according to the reports.Also, many adverse events were reported in the treated patients, but those were generally attributed to their already-severe illness at the time of treatment and other factors. Rashes were the only adverse reactions that seemed clearly related to the drug, but data gaps left the overall safety picture incomplete.”Despite extensive and thoughtful efforts, the post hoc data collection described in this issue provided a limited and incomplete view of the experience,” wrote Andrew T. Pavia, MD, a pediatric infectious disease expert at the University of Utah, in a commentary. “The EUA mechanism as described in the Project BioShield Act of 2004 was not designed for prospective data gathering.”Peramivir is a neuraminidase inhibitor, like oseltamivir (Tamiflu, given orally) and zanamivir (Relenza, given by inhalation), but is not yet licensed by the FDA. The FDA issued an EUA for peramivir on Oct 23, 2009, for the sake of seriously ill patients who needed an IV antiviral. The EUA remained in force until June 2010. The CDC managed distribution of the drug to clinicians who requested it.In one of the CID reports, CDC officials write that they received 1,371 clinician requests for peramivir and delivered 2,129 5-day adult-treatment course equivalents to 563 hospitals.Data from three surveys were used to estimate how many patients were treated. The surveys included a reminder survey about reporting adverse events, a hospital pharmacy survey, and a clinician survey seeking patient data. From these, the CDC estimated that at least 1,274 patients, median age 49, received the drug.The reminder survey results yielded data on 844 patients. Adverse events were reported in 260 (31%) of these, but most of the events could have been due to flu itself or underlying diseases, according to Pavia. Because of the survey design and the lack of a control group, the relationship of the adverse events to peramviir could not be determined, he said.The clinician survey drew a response rate of only 12%, with data on 127 patients. “The results paint a picture of very ill patients and late treatment,” Pavia commented. Ninety-two percent of the patients were on mechanical ventilation when peramivir treatment was started. When treatment ended, 30 (24%) of the patients had died. The available data did not permit a conclusion on whether the drug influenced outcomes.The second CID report was written by FDA officials who analyzed reports submitted to the Adverse Events Reporting System (AERS) about peramivir patients. The FDA received 369 reports covering 900 adverse events in 344 patients.The FDA investigators could not determine if any adverse events other than rash were due to peramivir, as missing data, severe illness, and other factors complicated the review, according to Pavia. The estimated overall mortality among the treated patients, about 16%, “did not differ from overall mortality of 14% to 46% in published series of hospitalized patients with pH1N1 influenza,” he wrote.Despite the limitations, the reports “highlight the first effective use of the EUA to provide a potentially lifesaving medication that was not yet licensed during a large-scale bioemergency,” Pavia wrote. “The delivery of drug to more than 1,100 critically ill patients within 24 hours of the request represents an enormous effort and logistical tour de force.”But he adds that the EUA was not initiated until close to the peak of the second wave of the pandemic, “and there may have been missed opportunities to make the drug available earlier.”Pavia suggests that more complete clinical data on patients treated under an EUA could be collected by providing data forms or links to secure Web sites when the drugs are delivered. Clinical research networks established in advance of emergencies would also improve data collection.The US House–passed version of the reauthorization for the Pandemic and All-Hazards Preparedness Act would expand the FDA’s ability to plan in advance for EUAs and to collect data during and after an emergency, but the Senate version does not include those provisions, Pavia said. Passage of the language in the House version is critical, he said.Yu Y, Garg S, Yu P, et al. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdmo9 under Emergency Use Authorization, October 2009 – June 2010. Clin Infect Dis 2012 (early online publication) [Abstract]Sorbello A, Jones SC, Carter W, et al. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clin Infect Dis 2012 (early online publication) [Abstract]Pavia AT. What did we learn from the Emergency Use Authorization of peramivir in 2009? (Commentary). Clin Infect Dis 2012 (early online publication) [Access page]See also: Oct 26, 2009, CIDRAP News storylast_img read more

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

first_imgGet instant access to must-read content today!To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $270. Subscribelast_img

first_imgGet your free guest access  SIGN UP TODAY Subscribe now for unlimited access To continue enjoying Building.co.uk, sign up for free guest accessExisting subscriber? LOGIN Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.Limited access to building.co.ukBreaking industry news as it happensBreaking, daily and weekly e-newsletters Subscribe to Building today and you will benefit from:Unlimited access to all stories including expert analysis and comment from industry leadersOur league tables, cost models and economics dataOur online archive of over 10,000 articlesBuilding magazine digital editionsBuilding magazine print editionsPrinted/digital supplementsSubscribe now for unlimited access.View our subscription options and join our communitylast_img read more

first_imgPatton has a fifteen-year background in industry and holds a degree in aeronautical science, from the Embry Riddle Aeronautical University.GCM supplies timbers for use in material handling and heavy lift operations. The matting is constructed of hardwood and oak timbers and is manufactured to a standard size. They are used in construction projects in a number of heavy industries – crane, petrochemical, refinery, pipeline, power, infrastructure and nuclear.last_img

first_img Recommended Do you see a typo or an error? Let us know. MIAMI (AP) A quarter-century after he vanished on the eve of a major drug indictment, the last of Miami’s fabled “cocaine cowboys” was in custody Thursday, nabbed on a suburban bike ride with his wife near Disney World.Prosecutors say the man living under an assumed name is Gustavo “Taby” Falcon, who was part of a homegrown drug gang that used super-fast speedboats to smuggle 75 tons of cocaine in the 1980s “Miami Vice” era.Falcon, 55, had been on the lam since 1991, when his older brother Augusto “Willie” Falcon and fellow drug kingpin Salvador “Sal” Magluta were indicted by a federal grand jury. U.S. Marshals spokesman Barry Golden said investigators were surprised to find him living in a typical pink stucco home in a quiet, middle-class Kissimmee suburb.“Nobody thought Gustavo Falcon was still in the United States,” Golden said.At his initial court hearing Thursday in Orlando, Gustavo Falcon agreed to be sent to South Florida to face charges of conspiracy to import cocaine into the U.S. He was ordered held without bond, court records show.Augusto Falcon and Magluta were small-time drug dealers when they dropped out of high school in the late 1970s to begin building their cocaine empire that would amass more than $2 billion, according to trial evidence. They eventually owned world-class ocean racing boats and lived like royalty.Mickey Munday, who did prison time for flying cocaine loads for Colombia’s Medellin Cartel, said the pair was known for their honesty in business deals – legal or otherwise – and the expertise of their boat-building operation.They also drove flashy cars and lived in seaside mansions, even when murders and shootings linked to their organization brought police scrutiny.“They were so flamboyant,” Munday said. “Everybody in the world knew what they were doing. Why attract attention to yourself?”Gustavo Falcon was not viewed as a top leader of the organization, and vanished just ahead of a 1991 indictment that charged him along with his brother, Magluta and others. He had not been seen since until Wednesday, when U.S. marshals surveilling his rented home in Kissimmee watched him and his wife leave their garage for a bike ride.A neighbor, David Pera, said he frequently saw the couple riding their bikes and never saw them in a car. An older model pickup truck sitting in the driveway never moved, he said.“I’d say hi, they would say hi, and that was about it,” Pera said Thursday.It took an exhaustive records search to bring the marshals there. Weeks earlier, they discovered a Florida driver’s license issued to a Luis Reiss, traced back to a South Florida home that had been owned by Gustavo Falcon. Then they found 2013 car accident involving Reiss, which eventually led to the house he was sharing with his wife, Amelia. She also had fake identification, in the name of Maria Reiss.Marshals followed as the couple got on their bikes and headed out Wednesday for what turned into a 40-mile ride. Because they were both wearing helmets and sunglasses, it took a while for investigators to make a positive identification, Golden said. Once they felt sure enough, marshals with guns drawn stopped the couple at an intersection a few blocks from their house.“We had to be 100 percent certain this was the guy,” Golden said.After his arrest, Gustavo Falcon told authorities he had been living in the Orlando area since 2009 and in the rental house since 2012. It’s not clear where he was during all the other years, but officials say it’s believed he was living overseas for some of that time. Authorities said they did not know if Falcon had a job. His wife was not arrested.His brother and Magluta were acquitted of all charges at their trial in 1996, leading to the resignation of then-Miami U.S. Attorney Kendall Coffey. Despondent at the loss, Coffey and others went to a strip club where he got into an altercation involving the biting of a stripper.Later, it turned out that Augusto Falcon and Magluta had bought off witnesses and at least one member of the jury, a foreman who did 17 years in prison after accepting $400,000. Magluta, now 62, was tried a second time, convicted of drug-related money laundering in 2002 and sentenced to 205 years in prison. That was reduced to 195 years in 2006.Augusto Falcon, now 61, then accepted a plea deal in 2003 on similar charges. He was sentenced to 20 years in prison and is scheduled for release from a Kentucky facility on June 17.Their mansions, boats, cars, planes, bank accounts and other ill-gotten gains are long gone, seized and sold by the government.Munday, the former cartel pilot, said Augusto Falcon and Magluta should have disappeared as well, after their initial not-guilty verdicts.“They were guys who went from nothing to having just about anything they could imagine that they wanted,” he said. “As soon as they got the innocent verdict, they should have hauled out of here to Argentina.” SHARE Deputies respond to Murphy USA gas station in Lehigh Acres Immokalee man arrested, faces second-degree murder for shooting death Author: Associated Press Published: April 13, 2017 5:36 PM EDT Marshals nab last of ‘cocaine cowboys,’ on lam for 26 years last_img read more

first_imgI introduced a debate at the 6 February Law Society Council meeting on how the council can better represent the profession. The Society encourages solicitors to take an active interest in equality and diversity, and yet our council does not reflect the diversity of the profession. I quoted statistics which show that: women constitute nearly half of the profession but fewer than one-third of the council; black and minority ethnic solicitors make up around 12% of the profession and 6% of the council; and younger solicitors are also under-represented, with those under the age of 35 accounting for around 35% of the profession and 5% of the council. Against this background, I made clear my view that a Law Society whose primary role is to represent the profession needs a council which is more representative of the profession. This is not a plea for perfect percentage ‘representativeness’ but it is a plea for improving where we are. We recognise that MPs, the judiciary and the police need to reflect our diverse society; equally, a council which more closely resembles the profession it represents is more likely to ensure that the Law Society remains focused on the needs and aspirations of the whole profession. Although the tasks that council undertakes have changed significantly since day-to-day regulation was delegated to the Solicitors Regulation Authority, it is still the apex of the governance structure of the Society. The officeholders, including the president, are the most visible outward-facing representatives of the Society, but it is council which agrees the annual presidential plan, changes to Law Society policy and rules, and the strategic direction of the Society’s work. Furthermore, council members populate the boards which deal with policy work on behalf of council. And our specialist committees, which provide so much expertise in their work for the profession, also have dedicated seats for council members. So why do so few people stand for council? Solicitors interested in legal politics are probably a small part of the profession, so that cuts down the numbers, and work pressures and other priorities reduce the numbers even more. But I suspect that another barrier might be misperceptions about what being a council member entails and how you can get to be one. Did you know that formal council meetings only take place six days a year? Or that anyone can stand in a constituency where they live or work? Many of those who are active in their local law society stand for council, but local law society membership or involvement is not a pre-condition to standing. For instance, I was first elected to council without having ever being a member of my local law society – although I am happily so now. And it is certainly not the case that years of experience in practice is necessary to be a useful council member. Solicitors who will still be working in the profession in 20 or 30 years, and who are ready and willing to seize the opportunities that new ways of thinking and working will bring to the profession, will have a great deal to offer. In our debate we discussed raising the profile of council elections to attract a more diverse pool of candidates and more voters – perhaps through better advertising or even media campaigning. We also discussed adjusting the working methods of the council that may be discouraging people from taking part – for example, the frequency, length and times of meetings. The debate has led to some fresh ideas that we will tell you about shortly, but there are elections coming up over the next couple of months that many of you will be eligible to stand in. I wanted to take this opportunity to alert you to them so you could start thinking about whether this would fit in with your future plans. If any of you want more information on council membership, or have any suggestions as to how we can make it as representative and relevant as possible, please contact me at: president@lawsociety.org.uk. Lucy Scott-Moncrieff is president of the Law Societylast_img read more